• Entecavir (BMS200475): HBV Research Workflows

  2026-09-26

  Build reproducible HBV replication assays with Entecavir (BMS200475), from DMSO stock preparation to viral DNA and viability readouts. A resistance-aware workflow helps distinguish antiviral response in treatment-naïve and lamivudine-resistant models while keeping assay findings in the right clinical context.

• TCAIM Tunes OGDH to Regulate Mitochondrial Metabolism

  2026-09-25

  A 2025 Molecular Cell study identifies the mitochondrial DNAJC co-chaperone TCAIM as a selective OGDH-binding factor that promotes lower OGDH protein levels through HSPA9 and LONP1. The resulting reduction in OGDH complex activity changes carbohydrate catabolism, revealing a proteostasis-based route for regulating mitochondrial metabolism.

• 7-AAD Cell Viability Assay Kit: Practical Guide

  2026-09-25

  Learn how the 7-AAD Cell Viability Assay Kit (SKU K2235) can support membrane-integrity measurements in flow cytometry, microscopy, and multiplex apoptosis workflows. This scenario-driven guide covers assay design, controls, interpretation, protocol parameters, and evidence-conscious product selection.

• CD44 Rewires Metabolism in IDH-Mutant Leukemia

  2026-09-24

  The study identifies CD44 as a metabolic dependency in IDH-mutant leukemia: it redirects glucose metabolism to sustain NADPH and R-2-hydroxyglutarate production. Its isogenic-cell design supports a mechanistic link between mutant IDH and CD44, while combination experiments point to a potential vulnerability that merits further testing alongside mutant-IDH inhibition.

• UK-5099 Workflows for Mitochondrial Immunometabolism

  2026-09-24

  Use UK-5099 to test how mitochondrial pyruvate entry contributes to cellular energy readouts and stimulated cytokine responses. This practical workflow adapts standardized whole-blood stimulation while distinguishing pathway-specific evidence from exploratory immune effects.

• LMO2–LDB1 Signaling in AML: Study Findings

  2026-09-23

  The study links LMO2 with the transcriptional co-regulator LDB1 in acute myeloid leukemia (AML), combining protein-interaction evidence with perturbation and gene-regulation analyses. Its findings support a role for LDB1 in AML-cell survival and proliferation and suggest that LMO2 contributes to this program, while leaving therapeutic relevance to be tested.

• Indazole Glucagon Receptor Antagonists: Study Insights

  2026-09-23

  Lin and colleagues reported a new indazole-, indole-, and azaindole-based series of glucagon receptor antagonists derived from the MK-0893 program. Their structure–activity relationship study produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity in humanized glucagon receptor mouse models.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-09-22

  Learn how the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive), SKU K1231, can strengthen mechanistic immunoblotting alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide covers membrane compatibility, signal optimization, interpretation, and practical product selection using documented performance characteristics and relevant ferroptosis research.

• 5-Azacytidine: Workflow for DNA Demethylation

  2026-09-22

  Build reproducible 5-Azacytidine experiments that connect DNMT inhibition with promoter methylation, gene reactivation, and cancer-cell phenotypes. The workflow adapts the HNF4A gastric-cancer findings into practical controls while preserving applications in leukemia and multiple myeloma research.

• LEE011 succinate: CDK4/6 Assay Workflows

  2026-09-21

  Build more informative CDK4/6 experiments with LEE011 succinate by combining proliferation, cell-cycle, and time-course readouts. This guide connects practical formulation and dosing choices with a dynamic biomarker concept from prostate cancer research while clearly separating evidence from assay-development recommendations.

• Cabazitaxel (XRP6258): Practical Lab Guide

  2026-09-21

  Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for studying antiproliferative responses and microtubule dynamics disruption, including taxane-resistant models. It should be prepared in DMSO or ethanol, used promptly, and excluded from water-only assays unless a separately validated formulation is available.

• IWP-2 Wnt Production Inhibitor: Applied Workflows

  2026-09-20

  IWP-2 is an upstream Wnt production inhibitor for separating ligand-dependent signaling from downstream cellular effects. This guide connects Porcupine inhibition with practical MKN28 proliferation, migration, transcriptional, and apoptosis workflows while emphasizing formulation control and cell-state-aware interpretation.

• Cyclopamine Workflows for Hedgehog Signaling Research

  2026-09-19

  Cyclopamine provides a practical way to connect Smoothened activity with measurable changes in proliferation, apoptosis, invasion, and developmental morphology. This workflow-oriented guide covers dose selection, controls, cross-species developmental assays, and troubleshooting for cancer research and Hedgehog biology.

• Gallein Workflow for GPCR Signaling Studies

  2026-09-18

  Gallein provides a practical way to test whether G protein βγ signaling contributes to GPCR-driven phenotypes in cancer, immune, cardiac, and emerging metabolic models. This guide combines literature-anchored use cases with concentration planning, assay workflows, and troubleshooting safeguards.

• Ibrexafungerp Against Fluconazole-Resistant C. auris

  2026-09-18

  Wiederhold and colleagues evaluated ibrexafungerp against fluconazole-resistant Candida auris using susceptibility testing and a delayed-treatment neutropenic mouse model. The study found consistent in vitro activity and improved survival and renal fungal clearance with ibrexafungerp, supporting further investigation of orally active glucan-synthesis inhibitors for difficult invasive candidiasis.

7940 records 1/530 page Next 12345 下5页 Last page